Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | London | GBP | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GSK | NYSE | USD | Real-time | |
GLAXF | OTC Markets | USD | Delayed | |
GSKN | Mexico | MXN | Delayed | |
GS70y | Frankfurt | EUR | Delayed | |
GS71 | Frankfurt | EUR | Delayed | |
GS71 | TradeGate | EUR | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 8052 | 8147 | 7178 | 6951 |
Gross Profit | 5237 | 5904 | 5279 | 5043 |
Operating Income | 1639 | 2556 | 2051 | 1769 |
Net Income | 350 | 1464 | 1624 | 1490 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 59005 | 60862 | 59461 | 58596 |
Total Liabilities | 46210 | 48243 | 47302 | 47284 |
Total Equity | 12795 | 12619 | 12159 | 11312 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 3196 | 2212 | 1307 | 53 |
Cash From Investing Activities | 268 | -491 | -964 | -408 |
Cash From Financing Activities | -3592 | -1762 | 31 | -318 |
Net Change in Cash | -162 | -18 | 317 | -704 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review